BRIEF published on 08/28/2024 at 09:05, 1 year 3 months ago Le Dr Jörg Schüttrumpf démissionne du conseil d'administration de Biotest AG Conseil D'administration Biotest AG Développement De Produits Jörg Schüttrumpf Groupe Grifols
PRESS RELEASE published on 08/28/2024 at 09:00, 1 year 3 months ago Dr. Jörg Schüttrumpf resigns from the Management Board of Biotest AG Dr. Jörg Schüttrumpf resigns as Chief Scientific Officer of Biotest AG to focus on role as Chief Scientific Innovation Officer of Grifols Group, effective August 31, 2024 Resignation Management Board Biotest AG Grifols Group Dr. Jörg Schüttrumpf
BRIEF published on 08/06/2024 at 09:05, 1 year 3 months ago Biotest Sees 35% Sales Spike in First Half of 2024 Financial Results Revenue Growth FDA Approval Biotest Yimmugo®
BRIEF published on 08/06/2024 at 09:05, 1 year 3 months ago Biotest voit ses ventes augmenter de 35 % au premier semestre 2024 Résultats Financiers Hausse Des Revenus Approbation De La FDA Biotest Yimmugo®
PRESS RELEASE published on 08/06/2024 at 09:00, 1 year 3 months ago Biotest increases sales in the first half of 2024 by 35% to Euro 372 million Biotest AG reports 35% sales increase to Euro 372 million in H1 2024. EBIT reaches Euro 78.4 million. FDA approves Yimmugo® and BNL facility. Positive revenue and earnings growth Revenue Growth FDA Approval Sales Increase Biotest AG H1 2024
BRIEF published on 07/30/2024 at 08:05, 1 year 4 months ago Biotest Reports 35% Increase in Sales for First Half of 2024 Financial Results Revenue Increase FDA Approval Sales Growth Biotest AG
BRIEF published on 07/30/2024 at 08:05, 1 year 4 months ago Biotest annonce une augmentation de 35 % de ses ventes pour le premier semestre 2024 Résultats Financiers Approbation De La FDA La Croissance Des Ventes Augmentation Des Revenus Biotest SA
PRESS RELEASE published on 07/30/2024 at 08:00, 1 year 4 months ago Biotest increases sales in the first half of 2024 by 35% to Euro 372 million Biotest AG increases sales by 35% to Euro 372 million in the first half of 2024. EBIT reaches €78.4 million. FDA approval received. Strategic deal with Kedrion estimated to yield $1 billion in 7 years FDA Approval EBIT Sales Increase Biotest AG €372 Million
BRIEF published on 07/01/2024 at 09:05, 1 year 5 months ago Biotest AG Prepares Yimmugo Launch in the USA, Secures Strategic Deal with Kedrion FDA Approval Biotest AG Yimmugo Kedrion Immunoglobulin
BRIEF published on 07/01/2024 at 09:05, 1 year 5 months ago Biotest AG prépare le lancement de Yimmugo aux États-Unis et conclut un accord stratégique avec Kedrion Approbation De La FDA Yimmugo Biotest SA Kedrion Immunoglobuline
Published on 12/05/2025 at 20:25, 36 minutes ago The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 20:15, 46 minutes ago When Proof Becomes Infrastructure, Markets Rewrite the Story (NASDAQ: SMX)
Published on 12/05/2025 at 19:50, 1 hour 11 minutes ago Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 1 hour 41 minutes ago The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 2 hours 16 minutes ago Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:58, 2 hours 3 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 2 hours 45 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:46, 3 hours 14 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:18, 3 hours 43 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 3 hours 43 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 5 hours 50 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 5 hours 50 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 7 hours 2 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
